Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)
| Image |  |
|---|---|
| Description | scientific article published on 23 October 2018 |
| Author/s |
author: Pellegrino Musto Roberto Ria |
| Publication date | October 23, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |